Paul No

Palliative Medicine

75 North Country Road
Port Jefferson, NY 11777

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Corrigendum: Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies.

Corrigendum: Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies.

Journal: Frontiers in immunology

Published: March 26, 2024

Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies.

Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies.

Journal: Frontiers in immunology

Published: August 03, 2023

The Virulence of Grief in the Pandemic: Bereavement Overload During COVID.

The Virulence of Grief in the Pandemic: Bereavement Overload During COVID.

Journal: The American journal of hospice & palliative care

Published: December 09, 2021

Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.

Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.

Journal: Cancer cell

Published: September 09, 2019

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer.

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer.

Journal: EBioMedicine

Published: December 06, 2018

Showing 1-5 of 5

Last Updated: 09/26/2026